Jaeseong Oh
Jeju City, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 89 publications
Authors' Reply to "Methodological and Outcome Interpretation Concerns for the Food-Effect Study of Bersiporocin" [Response to Letter].
Journal: Drug design, development and therapy
Published: August 05, 2026
On the robustness of truncated negative binomial regression model: application to field epidemiology.
Journal: Journal of applied statistics
Published: May 04, 2026
The Effect of Food on the Pharmacokinetics and Gastrointestinal Tolerability of Bersiporocin, a Novel Oral Prolyl-tRNA-Synthetase Inhibitor.
Journal: Drug design, development and therapy
Published: March 24, 2026
Clinical Application of Pharmacogenomics in Stroke Management: Current Evidence and Future Directions.
Journal: Journal of stroke
Published: September 16, 2025
Systemic T Cell Receptor Profiling Reveals Adaptive Immune Activation and Potential Immune Signatures of Diagnosis and Brain Atrophy in Epilepsy.
Journal: Annals of clinical and translational neurology
Published: May 14, 2025
Correction: Pharmacokinetics of post-transplant cyclophosphamide and its associations with clinical outcomes in pediatric haploidentical hematopoietic stem cell transplantation.
Journal: Biomarker research
Published: April 27, 2025
Dynamic biomarkers and Cox regression with time-dependent covariate for mortality prediction in severe fever with thrombocytopenia syndrome.
Journal: Scientific reports
Published: January 24, 2025
Prognostic nutritional index as an early predictor of mortality in patients with severe fever with thrombocytopenia syndrome: multicenter retrospective study in South Korea.
Journal: BMC infectious diseases
Published: December 23, 2024
5-Fluorouracil induces hair loss by inhibiting β-catenin signaling and angiogenesis.
Journal: Chemico-biological interactions
Published: October 29, 2024
Pharmacokinetics of post-transplant cyclophosphamide and its associations with clinical outcomes in pediatric haploidentical hematopoietic stem cell transplantation.
Journal: Biomarker research
Published: August 23, 2024
Pharmacokinetics, pharmacodynamics, safety, and tolerability of a single-dose riliprubart, an anti-C1s humanized monoclonal antibody in East-Asian adults: results from a Phase 1, randomized, open-label trial.
Journal: Expert opinion on investigational drugs
Published: August 22, 2024
Last Updated: 09/26/2026